H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data
Immunovant, Inc. (NASDAQ:IMVT) ranks among the best short squeeze stocks to invest in. On May 21, H.C. Wainwright boosted Immunovant, Inc.
Posts Tagged ‘NASDAQ:IMVT’
13 Best Short Squeeze Stocks to Invest In
US markets climbed to record highs, wrapping up a solid month, as President Trump announced he will soon make a decision on the Iran deal.
Truist Lifts PT on Immunovant, Inc. (IMVT) But Maintains a Hold Rating
Immunovant, Inc. (NASDAQ:IMVT) is one of the best momentum stocks to buy according to analysts. Truist lifted the price target on Immunovant, Inc.
10 Best Momentum Stocks to Buy According to Analysts
On May 22, Steve Sosnick, from Interactive Brokers, appeared on CNBC’s ‘Power Lunch’ to talk about what is driving the record market moves.
Immunovant (IMVT) Hits 5-Year High on Stellar Arthritis Treatment Trial
Immunovant saw its share prices soar to a new five-year high on Wednesday, as investors took heart from the stellar results of its clinical trial to study its drug candidate for...
10 Stocks With Insane Returns Right Now
On Wall Street, all three major indices finished in the green, led by the Nasdaq, up 1.54 percent, followed by the Dow Jones, jumping 1.31 percent, and the S&P 500, rising 1.08...
Immunovant, Inc. (IMVT) Analysts Raise Price Targets Following Q3 Earnings Update
Immunovant, Inc. (NASDAQ:IMVT) ranks among the most shorted stocks to buy according to analysts. On February 6, Immunovant, Inc.
11 Most Shorted Stocks to Buy According to Analysts
Although holes are starting to form, the stock market doesn't seem to be in danger of crashing just yet, with the S&P 500 down only 1% from its record high.
Immunovant, Inc. (NASDAQ:IMVT) Q3 2026 Earnings Call Transcript
Immunovant, Inc. (NASDAQ:IMVT) Q3 2026 Earnings Call Transcript February 6, 2026Immunovant, Inc. beats earnings expectations.
Truist Lifts Immunovant (IMVT) PT to $22 on Updated 2026 Financial Modeling
Immunovant Inc. (NASDAQ:IMVT) is one of the promising stocks to buy under $50.
10 Promising Stocks to Buy Under $50
On January 7, Jay Woods, Chief Market Strategist at Freedom Capital Markets, joined CNBC to state that stocks are broadening beyond tech, with materials, defense, transports, ...
Oppenheimer Maintains Outperform Rating on Immunovant (IMVT) Following Q2 2026 Earnings
Immunovant, Inc. (NASDAQ:IMVT) ranks among the best short squeeze stocks to buy right now.
12 Best Short Squeeze Stocks to Buy Right Now
As the year comes to a close, investors are keeping close tabs on the Federal Reserve's impending policy move, given the US shutdown-induced data shortage.
Immunovant, Inc. (NASDAQ:IMVT) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by. Welcome to the Roivant Second Quarter 2025 Earnings Call. [Operator Instructions] Please note that today's conference is being recorded.
Immunovant, Inc. (NASDAQ:IMVT) Q2 2026 Earnings Call Transcript
Immunovant, Inc. (NASDAQ:IMVT) Q2 2026 Earnings Call Transcript November 10, 2025Immunovant, Inc. misses on earnings expectations.
Immunovant (IMVT) Soars 14.6% Ahead of Q3 Results
Immunovant grew by 14.64 percent on Thursday to close at $24.82 apiece as investors gobbled up its shares ahead of the results of its third quarter earnings performance in the...
JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37
Immunovant, Inc. (NASDAQ:IMVT) is one of the best biotech stocks with high potential.
14 Biotech Stocks with High Potential
On October 1, Evan Seigerman, head of healthcare research at BMO Capital Markets, appeared on CNBC’s “The Exchange” to talk about what the future may be like for healthcare...
Where is Immunovant (IMVT) Heading According to Analysts?
Immunovant, Inc. (NASDAQ:IMVT) is one of the best strong buy stocks to invest in according to Wall Street.
12 Best Strong Buy Stocks to Invest in According to Wall Street
On September 26, Peter Boockvar, chief investment officer at One Point BFG Wealth Partners, appeared on CNBC to talk about the likelihood of the Federal Reserve’s interest rate...
12 Oversold NASDAQ Stocks to Buy Now
On July 14, Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.
LifeSci Capital Maintains a Buy on Immunovant (IMVT) With a $50 PT
Immunovant, Inc. (NASDAQ:IMVT) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.
13 Best Pharma Stocks to Buy According to Wall Street Analysts
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
Smart Money Ratings For 20 Most Undervalued Stocks
We have passed a quarter into 2025, and the U.S. economy sends mixed signals, causing investors to scramble and decode them. The U.S.
11 Stocks That Will Bounce Back According to Analysts
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.
10 Best Low Cost Stocks to Buy According to Billionaires
Markets are wobbling, and panic is becoming the headline. At times when stocks are tumbling, headlines are filled with forecasts that cause anxiety for investors.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and...
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US.
10 Stocks Insiders Spent The Most Money On Recently
As the broader market continues to rise this year, we thought it would be interesting to highlight some stocks that have seen significant insider buying recently.
12 Stocks That Will Double in 2025
A lot is happening in the market, especially within the growth sectors.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
10 Worst Performing Stocks to Buy on the Dip
Capital markets demonstrated increased volatility starting in August 2024 and continuing in September 2024.
Should You Hold Immunovant (IMVT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Billionaire Steve Cohen and Insiders are Buying These 5 Stocks
This article presents an overview of Billionaire Steve Cohen and Insiders are Buying These 5 Stocks. For a detailed overview of such stocks, read our article, Billionaire ...
11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now.
10 Stocks George Soros and Insiders Are Crazy About
In this article, we will take a detailed look at the 10 Stocks George Soros and Insiders Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks George...
5 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold healthcare stocks to buy right now.
Should You Invest in Immunovant (IMVT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Immunovant (IMVT) Rose on Positive Clinical Trial
Chartwell Investment Partners, LLC, an affiliate of Carillon Tower Advisers, Inc., released the “Carillon Chartwell Small Cap Value Fund” third quarter 2023 investor letter...
11 Stocks Insiders and Billionaires Are Crazy About
In this article, we will take a detailed look at the 11 Stocks Insiders and Billionaires Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks Insiders...
Here’s Why Immunovant (IMVT) Outperformed in Q3
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” third quarter 2023 investor letter.
15 Best-Performing Stocks in the Last 12 Months
In this article, we will take a look at the 15 best-performing stocks in the last 12 months.
12 Best Small-Cap Healthcare Stocks To Buy Now
In this article, we discuss 12 best small-cap healthcare stocks to buy now.
These 10 Stocks are Getting Crushed on Monday
In this article, we will take a look at the 10 stocks getting crushed on Monday.
Hedge Funds Are Dumping Immunovant, Inc. (IMVT)
A whopping number of 13F filings filed with U.S.
Hedge Fund and Insider Trading News: David Rosen, Bill Ackman, Jana Partners, Magnetar Capital, Millennium Management, Alden Global Capital, America’s Car-Mart, Inc. (CRMT), Restaurant Brands International Inc (QSR), and More
Activist investor Jana Partners has called on Vonage Holdings Inc.
5 Best Biotech Stocks to Buy According to Alan Frazier
In this article, we discuss the 5 best dividend stocks to buy according to Alan Frazier.
Is Immunovant, Inc. (IMVT) Going to Burn These Hedge Funds?
In this article we will take a look at whether hedge funds think Immunovant, Inc. (NASDAQ:IMVT) is a good investment right now.
Is IMVT Stock A Buy or Sell?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Hedge Fund Resource Center
